Photodynamic Therapy Market Report 2026

Photodynamic Therapy Market Overview

• Photodynamic Therapy market size has reached to $1.53 billion in 2025 • Expected to grow to $2.04 billion in 2030 at a compound annual growth rate (CAGR) of 5.9% • Growth Driver: Rising Prevalence Of Skin Cancer Drives Growth In The Photodynamic Therapy Market • Market Trend: Clinical Trials Explore Photodynamic Therapy Combinations For Enhanced Treatment Efficacy • North America was the largest region in 2025.

What Is Covered Under Photodynamic Therapy Market?

Photodynamic therapy refers to a procedure that uses a light source and medication that is light-sensitive to eliminate aberrant cells. Some eye and skin disorders, as well as specific cancers, can be treated with it. Photodynamic therapy (PDT) is a two-stage treatment that combines light energy with a drug (photosensitizer) designed to destroy cancerous and precancerous cells after light activation. The main types of products in the photodynamic therapy market are drugs and devices. PDT drugs are light-sensitive drugs that get activated with certain kinds of lights and destroy abnormal cells to treat various diseases. PDT devices include lamps, LED devices, and other devices that emit light to activate PDT drugs. Photodynamic therapy is used in the treatment of various diseases such as acne, actinic keratosis, cancer, and psoriasis, others and is implemented in various sectors such as cosmetics and dermatology clinics, hospitals, cancer treatment centers, and others.

What Is The Photodynamic Therapy Market Growth Forecast?

The photodynamic therapy market size is expected to see strong growth in the next few years. It will grow to $2.04 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to advancements in novel photosensitizer formulations, expanding applications beyond oncology, increasing demand for outpatient therapies, growing investment in cancer treatment infrastructure, rising preference for targeted and precision therapies. Major trends in the forecast period include expansion of photodynamic therapy in oncology, growing adoption in dermatology and aesthetic treatments, development of next-generation photosensitizers, shift toward minimally invasive cancer treatments, rising use of combination therapy approaches.

Global Photodynamic Therapy Market Segmentation

1) By Product: Drugs, Devices 2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications 3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users Subsegments: 1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations 2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

What Is The Driver Of The Photodynamic Therapy Market?

The rising prevalence of skin cancer is contributing to the growth of the photodynamic therapy market. Skin cancer is observed to be the most common cancer of all cancers. Melanoma contributes to only about 1% of skin cancers but causes a large number of skin cancer deaths. Photodynamic treatment (PDT) uses a combination of a light-sensitizing medication and very intense light to destroy cancer cells. The doctor applies a light-sensitizing chemical-containing lotion to the skin cancer and the surrounding area. For instance, in 2023, according to Cancer Australia, an Australia-based government agency, approximately 8,257 new cases of melanoma of the skin were diagnosed, accounting for 2.6% of all deaths from cancer. Therefore, the increasing prevalence of skin cancer is expected to fuel the growth of the photodynamic therapy industry in the coming years.

Key Players In The Global Photodynamic Therapy Market

Major companies operating in the photodynamic therapy market are Galderma S.A., Bausch Health, Lumenis Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Hologic Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de Produtos Farmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

Global Photodynamic Therapy Market Trends and Insights

Major companies operating in the photodynamic therapy (PDT) market are increasingly focusing on clinical trials to evaluate PDT in combination with different drugs for enhanced therapeutic outcomes. Photodynamic therapy involves using light-activated compounds to selectively target and destroy cancerous or diseased cells. For instance, in February 2024, Kintara Therapeutics, a US-based biotechnology company, initiated a clinical trial for its REM-001 therapy targeting cutaneous metastatic breast cancer (CMBC). The open-label study (NCT05374915) involves 15 patients and evaluates the second-generation PDT agent REM-001 at a 0.8 mg dose. The trial aims to optimize study design ahead of a Phase 3 trial, focusing on the Best Overall Objective Response Rate (bORR) within 24 weeks, with primary endpoints measuring complete and partial responses in treated fields.

What Are Latest Mergers And Acquisitions In The Photodynamic Therapy Market?

In February 2023, Omni Partners LLP, a UK-based investment management firm, completed the acquisition of Aesthetic Technology Ltd for an undisclosed amount. With this acquisition, Omni Partners aims to improve new technologies in healthcare, especially those that provide effective options for aesthetic and medical treatments. Aesthetic Technology Limited is a UK-based medical equipment manufacturer specializing in innovative energy-based devices for the medical, aesthetic, and cosmetic markets.

Regional Insights

North America was the largest region in the photodynamic therapy market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Photodynamic Therapy Market?

The photodynamic therapy market includes revenues earned by entities by treating actinic keratoses and superficial basal cell carcinomas. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Photodynamic Therapy Market Report 2026?

The photodynamic therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the photodynamic therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.